Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 24;14(5):1161.
doi: 10.3390/cancers14051161.

Contemporary Management of Locally Advanced and Recurrent Rectal Cancer: Views from the PelvEx Collaborative

Collaborators
Review

Contemporary Management of Locally Advanced and Recurrent Rectal Cancer: Views from the PelvEx Collaborative

PelvEx Collaborative. Cancers (Basel). .

Abstract

Pelvic exenteration is a complex operation performed for locally advanced and recurrent pelvic cancers. The goal of surgery is to achieve clear margins, therefore identifying adjacent or involved organs, bone, muscle, nerves and/or vascular structures that may need resection. While these extensive resections are potentially curative, they can be associated with substantial morbidity. Recently, there has been a move to centralize care to specialized units, as this facilitates better multidisciplinary care input. Advancements in pelvic oncology and surgical innovation have redefined the boundaries of pelvic exenterative surgery. Combined with improved neoadjuvant therapies, advances in diagnostics, and better reconstructive techniques have provided quicker recovery and better quality of life outcomes, with improved survival This article provides highlights of the current management of advanced pelvic cancers in terms of surgical strategy and potential future developments.

Keywords: diagnostics; locally advanced rectal cancer; perioperative care; quality of life; rectal cancer; recurrent rectal cancer; surgical management; surgical outcomes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Maximizing success in pelvic exenterative surgery.

References

    1. PelvEx Collaborative Minimally invasive surgery techniques in pelvic exenteration: A systematic and meta-analysis review. Surg. Endosc. 2018;32:4707–4715. doi: 10.1007/s00464-018-6299-5. - DOI - PubMed
    1. Waters P.S., Peacock O., Warrier S.K., Wakeman C., Eglinton T., Lynch A.C., Frizelle F.A., Heriot A.G., McCormick J. Evolution of pelvic exenteration surgery–resectional trends and survival outcomes over three decades. Eur. J. Surg. Oncol. 2019;45:2325–2333. doi: 10.1016/j.ejso.2019.07.015. - DOI - PubMed
    1. Quyn A.J., Solomon M., Lee P.M., Badgery-Parker T., Masya L.M., Young J.M. Palliative Pelvic Exenteration: Clinical Outcomes and Quality of Life. Dis. Colon Rectum. 2016;59:1005–1010. doi: 10.1097/DCR.0000000000000679. - DOI - PubMed
    1. Steffens D., Solomon M.J., Young J.M., Koh C., Venchiarutti R.L., Lee P., Austin K. Cohort study of long-term survival and quality of life following pelvic exenteration. BJS Open. 2018;2:328–335. doi: 10.1002/bjs5.75. - DOI - PMC - PubMed
    1. PelvEx Collaborative Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer. BJS Open. 2019;3:516–520. doi: 10.1002/bjs5.50153. - DOI - PMC - PubMed

LinkOut - more resources